Our Company

The work we do today holds the potential to transform lives tomorrow

Founded in 2009, Corbus is a clinical-stage pharmaceutical company advancing new treatments for cancer and obesity, two of the most urgent health challenges of our time.

We are experienced scientists, clinicians, and industry leaders. Our day-to-day work is shaped by deep biological insight and a patient-first mindset inspiring everything we do.

Our pipeline includes an antibody-drug conjugate targeting cancer cells, a tumor growth inhibitor, and an exciting oral treatment for obesity, breakthrough treatments designed with the potential to transform patient lives.

Every decision we make is guided by the belief that people deserve better options.

Discover How We're Advancing Treatments That Can Transform Patient Lives